Press coverage about CryoPort (NASDAQ:CYRX) has been trending somewhat positive on Monday, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CryoPort earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave media coverage about the consumer goods maker an impact score of 46.4366918065987 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
A number of brokerages have recently commented on CYRX. BidaskClub raised CryoPort from a “hold” rating to a “buy” rating in a research report on Friday. ValuEngine raised CryoPort from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $11.00 price target (up previously from $10.00) on shares of CryoPort in a research report on Thursday, March 8th. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $11.63.
Get CryoPort alerts:Shares of NASDAQ CYRX opened at $12.02 on Monday. CryoPort has a one year low of $3.08 and a one year high of $12.08. The firm has a market cap of $330.73 million, a PE ratio of -35.35 and a beta of 0.71.
CryoPort (NASDAQ:CYRX) last issued its quarterly earnings results on Thursday, May 3rd. The consumer goods maker reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.03). CryoPort had a negative net margin of 66.29% and a negative return on equity of 48.12%. The firm had revenue of $4.02 million for the quarter, compared to analysts’ expectations of $3.84 million. During the same period in the prior year, the company earned ($0.10) EPS. The firm’s quarterly revenue was up 48.3% on a year-over-year basis. sell-side analysts forecast that CryoPort will post -0.29 earnings per share for the current fiscal year.
In other news, CEO Jerrell Shelton sold 29,257 shares of the company’s stock in a transaction on Tuesday, March 13th. The stock was sold at an average price of $9.83, for a total transaction of $287,596.31. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 9.60% of the stock is owned by corporate insiders.
CryoPort Company Profile
Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.
No comments:
Post a Comment